FDA Approves Unknown Drug — INVAGEN PHARMS

# FDA Approves ANDA Application for INVAGEN PHARMS InvaGen Pharmaceuticals has received FDA approval for ANDA218768, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceuticals sector. The approval is expected to provide patients with more affordable treatment options while contributing to InvaGen's revenue growth through increased generic drug offerings.